Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pregnancy Complications, Infectious | 23 | 2025 | 2185 | 5.190 |
Why?
|
Placenta | 19 | 2024 | 1725 | 4.200 |
Why?
|
Fetal Development | 7 | 2020 | 779 | 1.940 |
Why?
|
Pregnancy | 71 | 2025 | 30256 | 1.850 |
Why?
|
Microglia | 5 | 2024 | 1376 | 1.790 |
Why?
|
Fetal Blood | 6 | 2025 | 1361 | 1.620 |
Why?
|
Prenatal Exposure Delayed Effects | 7 | 2024 | 2538 | 1.390 |
Why?
|
Antibodies, Viral | 14 | 2024 | 3216 | 1.330 |
Why?
|
Serine Endopeptidases | 4 | 2021 | 1027 | 1.220 |
Why?
|
Fetus | 8 | 2024 | 1883 | 1.190 |
Why?
|
Infectious Disease Transmission, Vertical | 8 | 2022 | 1354 | 1.170 |
Why?
|
Metabolic Diseases | 4 | 2024 | 684 | 1.140 |
Why?
|
Lactation | 5 | 2023 | 392 | 1.110 |
Why?
|
Fetal Death | 3 | 2022 | 434 | 1.060 |
Why?
|
Amniotic Fluid | 6 | 2015 | 381 | 0.970 |
Why?
|
Pregnancy Complications | 6 | 2016 | 2973 | 0.860 |
Why?
|
Fetal Distress | 1 | 2022 | 39 | 0.800 |
Why?
|
Antibody Formation | 3 | 2022 | 1393 | 0.760 |
Why?
|
Psychological Tests | 1 | 2023 | 643 | 0.750 |
Why?
|
Pregnancy Trimester, Second | 7 | 2015 | 737 | 0.700 |
Why?
|
Obesity | 11 | 2024 | 13090 | 0.700 |
Why?
|
Macrophages | 4 | 2024 | 5799 | 0.700 |
Why?
|
Immunity, Maternally-Acquired | 1 | 2020 | 112 | 0.690 |
Why?
|
Specimen Handling | 3 | 2024 | 708 | 0.670 |
Why?
|
Gene Expression Regulation, Developmental | 3 | 2016 | 3610 | 0.670 |
Why?
|
Infant, Newborn | 21 | 2024 | 26422 | 0.620 |
Why?
|
Female | 81 | 2025 | 397192 | 0.590 |
Why?
|
Postpartum Period | 4 | 2022 | 1198 | 0.570 |
Why?
|
Brain | 7 | 2024 | 27360 | 0.490 |
Why?
|
Maternal-Fetal Exchange | 2 | 2020 | 454 | 0.490 |
Why?
|
Gene Expression Profiling | 6 | 2024 | 9538 | 0.490 |
Why?
|
Leukocytes, Mononuclear | 2 | 2024 | 1854 | 0.490 |
Why?
|
Immunity | 5 | 2022 | 1003 | 0.450 |
Why?
|
Prosencephalon | 1 | 2016 | 305 | 0.450 |
Why?
|
Vaccination | 7 | 2025 | 3437 | 0.410 |
Why?
|
Mothers | 3 | 2023 | 2209 | 0.410 |
Why?
|
Humans | 83 | 2025 | 768166 | 0.400 |
Why?
|
Self Report | 1 | 2023 | 3773 | 0.390 |
Why?
|
Estrogens, Non-Steroidal | 1 | 2012 | 52 | 0.390 |
Why?
|
Patient Participation | 1 | 2020 | 1447 | 0.370 |
Why?
|
Sex Factors | 4 | 2024 | 10632 | 0.370 |
Why?
|
Phenols | 2 | 2012 | 526 | 0.370 |
Why?
|
Vacuum Curettage | 1 | 2011 | 44 | 0.360 |
Why?
|
Nervous System | 1 | 2014 | 544 | 0.360 |
Why?
|
Nuchal Translucency Measurement | 1 | 2011 | 59 | 0.350 |
Why?
|
Maternal Exposure | 2 | 2021 | 1096 | 0.350 |
Why?
|
Pregnancy, Multiple | 1 | 2011 | 216 | 0.340 |
Why?
|
Labor, Induced | 1 | 2011 | 156 | 0.330 |
Why?
|
Twins | 1 | 2011 | 341 | 0.320 |
Why?
|
Mental Health | 1 | 2023 | 3275 | 0.320 |
Why?
|
Adult | 35 | 2025 | 223646 | 0.320 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2021 | 1887 | 0.320 |
Why?
|
Databases, Genetic | 2 | 2015 | 1758 | 0.310 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3115 | 0.310 |
Why?
|
Pre-Eclampsia | 4 | 2016 | 1255 | 0.310 |
Why?
|
Puerperal Disorders | 3 | 2023 | 304 | 0.300 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3238 | 0.300 |
Why?
|
Abortion, Spontaneous | 3 | 2021 | 535 | 0.290 |
Why?
|
Cardiovascular Diseases | 3 | 2023 | 15662 | 0.290 |
Why?
|
Immunoglobulin G | 5 | 2022 | 4568 | 0.280 |
Why?
|
Pandemics | 10 | 2023 | 8748 | 0.260 |
Why?
|
Neck | 1 | 2011 | 736 | 0.260 |
Why?
|
Nervous System Diseases | 1 | 2016 | 1662 | 0.250 |
Why?
|
Checklist | 2 | 2023 | 840 | 0.250 |
Why?
|
Infant | 11 | 2024 | 36535 | 0.250 |
Why?
|
Abortion, Induced | 1 | 2011 | 471 | 0.240 |
Why?
|
Systemic Inflammatory Response Syndrome | 4 | 2023 | 621 | 0.230 |
Why?
|
Hydrogen | 1 | 2024 | 171 | 0.220 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 1 | 2024 | 126 | 0.220 |
Why?
|
Trophoblasts | 2 | 2021 | 223 | 0.210 |
Why?
|
MicroRNAs | 2 | 2016 | 3803 | 0.210 |
Why?
|
Cytokines | 4 | 2025 | 7453 | 0.200 |
Why?
|
Child Development | 2 | 2024 | 2330 | 0.200 |
Why?
|
Progestins | 1 | 2024 | 302 | 0.200 |
Why?
|
Chorioamnionitis | 2 | 2022 | 156 | 0.200 |
Why?
|
Perinatology | 1 | 2022 | 64 | 0.190 |
Why?
|
Animals | 13 | 2024 | 169246 | 0.180 |
Why?
|
Child | 16 | 2024 | 80917 | 0.180 |
Why?
|
Hematologic Tests | 1 | 2022 | 239 | 0.180 |
Why?
|
Haptoglobins | 1 | 2021 | 165 | 0.170 |
Why?
|
Male | 20 | 2024 | 364719 | 0.170 |
Why?
|
Isoflurane | 1 | 2023 | 384 | 0.170 |
Why?
|
Parturition | 1 | 2023 | 455 | 0.170 |
Why?
|
Gestational Age | 5 | 2024 | 3621 | 0.170 |
Why?
|
Prospective Studies | 8 | 2024 | 54926 | 0.160 |
Why?
|
Case-Control Studies | 8 | 2024 | 22291 | 0.160 |
Why?
|
Placenta Diseases | 1 | 2021 | 199 | 0.160 |
Why?
|
Microtubule-Associated Proteins | 1 | 2024 | 1074 | 0.160 |
Why?
|
Dexmedetomidine | 1 | 2023 | 320 | 0.160 |
Why?
|
Cohort Studies | 6 | 2024 | 41754 | 0.150 |
Why?
|
Diabetes, Gestational | 2 | 2024 | 1263 | 0.150 |
Why?
|
Mice | 7 | 2024 | 82029 | 0.150 |
Why?
|
Disease Models, Animal | 4 | 2020 | 18349 | 0.150 |
Why?
|
Adiponectin | 1 | 2024 | 1117 | 0.150 |
Why?
|
Perinatal Care | 1 | 2020 | 245 | 0.150 |
Why?
|
RNA, Messenger | 5 | 2024 | 12800 | 0.150 |
Why?
|
Prenatal Diagnosis | 2 | 2016 | 1275 | 0.140 |
Why?
|
Hallucinogens | 1 | 2021 | 212 | 0.140 |
Why?
|
Propofol | 1 | 2023 | 608 | 0.140 |
Why?
|
Protein Precursors | 1 | 2021 | 1134 | 0.140 |
Why?
|
Influenza A virus | 1 | 2020 | 460 | 0.140 |
Why?
|
Milk, Human | 1 | 2021 | 490 | 0.140 |
Why?
|
Insulin Resistance | 2 | 2024 | 3986 | 0.130 |
Why?
|
Body Mass Index | 4 | 2024 | 13053 | 0.130 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2016 | 3800 | 0.130 |
Why?
|
Maternal Health Services | 1 | 2022 | 472 | 0.130 |
Why?
|
Abdominal Pain | 1 | 2022 | 1070 | 0.130 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2022 | 617 | 0.130 |
Why?
|
Autophagy | 1 | 2024 | 1349 | 0.130 |
Why?
|
Massachusetts | 3 | 2024 | 8890 | 0.130 |
Why?
|
Immunoglobulin M | 1 | 2020 | 1528 | 0.130 |
Why?
|
Premature Birth | 1 | 2007 | 1829 | 0.120 |
Why?
|
Sinus Thrombosis, Intracranial | 1 | 2016 | 111 | 0.120 |
Why?
|
Fever | 1 | 2022 | 1614 | 0.120 |
Why?
|
Myocarditis | 1 | 2023 | 802 | 0.120 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2024 | 2062 | 0.120 |
Why?
|
Pregnancy Trimester, Third | 2 | 2020 | 587 | 0.120 |
Why?
|
Cannabis | 1 | 2021 | 446 | 0.120 |
Why?
|
Glucocorticoids | 1 | 2024 | 2167 | 0.120 |
Why?
|
Histone Code | 1 | 2015 | 160 | 0.120 |
Why?
|
Cell Separation | 1 | 2020 | 1728 | 0.120 |
Why?
|
Viral Load | 2 | 2020 | 3396 | 0.120 |
Why?
|
Breast Feeding | 1 | 2023 | 1363 | 0.120 |
Why?
|
RNA | 2 | 2015 | 2720 | 0.110 |
Why?
|
Carotid Artery, Internal, Dissection | 1 | 2014 | 39 | 0.110 |
Why?
|
Pregnancy Outcome | 3 | 2011 | 2972 | 0.110 |
Why?
|
History, 21st Century | 1 | 2020 | 1573 | 0.110 |
Why?
|
Retrospective Studies | 6 | 2024 | 81762 | 0.110 |
Why?
|
Amniocentesis | 1 | 2014 | 116 | 0.110 |
Why?
|
Vertebral Artery Dissection | 1 | 2014 | 48 | 0.110 |
Why?
|
Fetofetal Transfusion | 1 | 2015 | 117 | 0.110 |
Why?
|
Vaccines | 1 | 2022 | 842 | 0.110 |
Why?
|
Ultrasonography, Prenatal | 2 | 2012 | 1772 | 0.110 |
Why?
|
Principal Component Analysis | 1 | 2016 | 948 | 0.100 |
Why?
|
Molecular Sequence Annotation | 1 | 2015 | 527 | 0.100 |
Why?
|
Term Birth | 1 | 2013 | 140 | 0.100 |
Why?
|
Computational Biology | 2 | 2015 | 3568 | 0.100 |
Why?
|
Fetal Weight | 1 | 2012 | 88 | 0.100 |
Why?
|
Lipids | 1 | 2023 | 3343 | 0.100 |
Why?
|
RNA, Viral | 1 | 2020 | 2872 | 0.100 |
Why?
|
Mice, Inbred C57BL | 2 | 2024 | 22379 | 0.100 |
Why?
|
Young Adult | 10 | 2024 | 60066 | 0.100 |
Why?
|
Phosphoproteins | 1 | 2020 | 2451 | 0.100 |
Why?
|
Lipopolysaccharides | 1 | 2018 | 2219 | 0.090 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2024 | 4648 | 0.090 |
Why?
|
Chorion | 1 | 2011 | 113 | 0.090 |
Why?
|
Acute Disease | 2 | 2023 | 7243 | 0.090 |
Why?
|
Birth Weight | 2 | 2023 | 2121 | 0.090 |
Why?
|
Intestinal Mucosa | 1 | 2021 | 3044 | 0.090 |
Why?
|
Cytogenetic Analysis | 1 | 2011 | 271 | 0.090 |
Why?
|
Retinopathy of Prematurity | 1 | 2015 | 450 | 0.080 |
Why?
|
Neutrophils | 1 | 2022 | 3786 | 0.080 |
Why?
|
Neural Tube Defects | 1 | 2012 | 255 | 0.080 |
Why?
|
Amnion | 1 | 2011 | 204 | 0.080 |
Why?
|
Tachycardia, Supraventricular | 1 | 2002 | 273 | 0.080 |
Why?
|
Nucleic Acids | 1 | 2012 | 189 | 0.080 |
Why?
|
Organ Specificity | 1 | 2014 | 1968 | 0.080 |
Why?
|
United States | 4 | 2022 | 73039 | 0.080 |
Why?
|
Catheter Ablation | 2 | 2003 | 2780 | 0.080 |
Why?
|
Gene Expression | 1 | 2021 | 7598 | 0.080 |
Why?
|
Karyotyping | 1 | 2011 | 1177 | 0.080 |
Why?
|
Receptors, Fc | 2 | 2022 | 537 | 0.080 |
Why?
|
Hypertension | 1 | 2008 | 8616 | 0.080 |
Why?
|
Severity of Illness Index | 3 | 2021 | 15948 | 0.080 |
Why?
|
Receptors, IgG | 2 | 2022 | 564 | 0.080 |
Why?
|
Headache | 1 | 2016 | 1263 | 0.080 |
Why?
|
Aneuploidy | 1 | 2012 | 573 | 0.080 |
Why?
|
Patient Selection | 1 | 2020 | 4260 | 0.080 |
Why?
|
Public Health | 1 | 2021 | 2679 | 0.080 |
Why?
|
Benzhydryl Compounds | 2 | 2012 | 944 | 0.080 |
Why?
|
Endocrine Disruptors | 1 | 2011 | 265 | 0.070 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2002 | 775 | 0.070 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2011 | 1534 | 0.070 |
Why?
|
Sequence Analysis, RNA | 1 | 2015 | 2040 | 0.070 |
Why?
|
Hyperglycemic Hyperosmolar Nonketotic Coma | 1 | 2007 | 30 | 0.070 |
Why?
|
Abortion, Habitual | 1 | 2007 | 63 | 0.070 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2018 | 4352 | 0.070 |
Why?
|
Child, Preschool | 7 | 2024 | 42669 | 0.070 |
Why?
|
Down Syndrome | 1 | 2015 | 919 | 0.070 |
Why?
|
Health Resources | 1 | 2003 | 950 | 0.070 |
Why?
|
Epigenesis, Genetic | 2 | 2021 | 3833 | 0.070 |
Why?
|
Athletic Injuries | 1 | 2007 | 1245 | 0.070 |
Why?
|
Pregnancy Trimester, First | 1 | 2011 | 917 | 0.070 |
Why?
|
Population Surveillance | 1 | 2007 | 2596 | 0.070 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2023 | 4640 | 0.060 |
Why?
|
Fetal Growth Retardation | 1 | 2009 | 592 | 0.060 |
Why?
|
Rats | 2 | 2023 | 23760 | 0.060 |
Why?
|
Receptors, Adiponectin | 1 | 2024 | 82 | 0.060 |
Why?
|
Depression | 1 | 2023 | 8230 | 0.060 |
Why?
|
Pregnanolone | 1 | 2024 | 67 | 0.060 |
Why?
|
Seizures | 1 | 2016 | 2998 | 0.050 |
Why?
|
Cesarean Section | 1 | 2012 | 1425 | 0.050 |
Why?
|
Gases | 1 | 2023 | 205 | 0.050 |
Why?
|
Tetanus Toxoid | 1 | 2022 | 188 | 0.050 |
Why?
|
National Institute of Child Health and Human Development (U.S.) | 1 | 2021 | 25 | 0.050 |
Why?
|
Immunoglobulin Isotypes | 1 | 2021 | 158 | 0.050 |
Why?
|
Dyslipidemias | 1 | 2008 | 873 | 0.050 |
Why?
|
DNA Methylation | 1 | 2015 | 4428 | 0.050 |
Why?
|
Multigene Family | 1 | 2024 | 1081 | 0.050 |
Why?
|
Quality of Life | 2 | 2003 | 13490 | 0.040 |
Why?
|
Software | 1 | 2015 | 4478 | 0.040 |
Why?
|
Time | 2 | 2003 | 552 | 0.040 |
Why?
|
Pilot Projects | 1 | 2014 | 8741 | 0.040 |
Why?
|
Prevalence | 3 | 2020 | 15869 | 0.040 |
Why?
|
Time Factors | 1 | 2022 | 40218 | 0.040 |
Why?
|
Asymptomatic Infections | 1 | 2021 | 136 | 0.040 |
Why?
|
Immunity, Humoral | 1 | 2024 | 610 | 0.040 |
Why?
|
Viremia | 1 | 2022 | 726 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2024 | 1737 | 0.040 |
Why?
|
Adolescent | 7 | 2023 | 89169 | 0.040 |
Why?
|
Permeability | 1 | 2021 | 725 | 0.040 |
Why?
|
Genomics | 1 | 2015 | 5926 | 0.040 |
Why?
|
Health Care Costs | 1 | 2002 | 3239 | 0.040 |
Why?
|
Progesterone | 1 | 2023 | 752 | 0.040 |
Why?
|
Viral Envelope Proteins | 1 | 2022 | 640 | 0.040 |
Why?
|
Microscopy, Electron | 1 | 2021 | 2560 | 0.040 |
Why?
|
Longitudinal Studies | 2 | 2024 | 14783 | 0.040 |
Why?
|
Genotype | 1 | 2012 | 13045 | 0.040 |
Why?
|
In Situ Hybridization | 1 | 2021 | 1903 | 0.040 |
Why?
|
Feces | 1 | 2024 | 1511 | 0.040 |
Why?
|
Immunoglobulin A | 1 | 2021 | 992 | 0.040 |
Why?
|
Carrier State | 1 | 2021 | 529 | 0.030 |
Why?
|
Antigens, Viral | 1 | 2021 | 995 | 0.030 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2023 | 1988 | 0.030 |
Why?
|
Herpesvirus 4, Human | 1 | 2022 | 1082 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2021 | 1864 | 0.030 |
Why?
|
Down-Regulation | 1 | 2024 | 2937 | 0.030 |
Why?
|
Risk Factors | 4 | 2021 | 74944 | 0.030 |
Why?
|
Antibodies, Bacterial | 1 | 2022 | 1479 | 0.030 |
Why?
|
HIV Infections | 1 | 2022 | 17569 | 0.030 |
Why?
|
Anesthesia, General | 1 | 2023 | 1189 | 0.030 |
Why?
|
Estradiol | 1 | 2023 | 1951 | 0.030 |
Why?
|
Oligopeptides | 1 | 2021 | 1194 | 0.030 |
Why?
|
ROC Curve | 1 | 2023 | 3628 | 0.030 |
Why?
|
HIV | 1 | 2022 | 1597 | 0.030 |
Why?
|
Trauma Severity Indices | 1 | 2007 | 479 | 0.030 |
Why?
|
Guidelines as Topic | 1 | 2021 | 1397 | 0.030 |
Why?
|
HELLP Syndrome | 1 | 2014 | 40 | 0.030 |
Why?
|
Algorithms | 1 | 2015 | 14164 | 0.030 |
Why?
|
Atrial Fibrillation | 1 | 2003 | 5176 | 0.030 |
Why?
|
Autoantibodies | 1 | 2023 | 2121 | 0.030 |
Why?
|
Fertilization in Vitro | 1 | 2022 | 1303 | 0.030 |
Why?
|
Age of Onset | 1 | 2021 | 3347 | 0.030 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2023 | 6029 | 0.030 |
Why?
|
Weight Gain | 1 | 2023 | 2359 | 0.030 |
Why?
|
New Mexico | 1 | 2003 | 81 | 0.030 |
Why?
|
Cell-Free System | 1 | 2013 | 339 | 0.030 |
Why?
|
Angiography, Digital Subtraction | 1 | 2014 | 331 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 1 | 2023 | 8128 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2024 | 4415 | 0.020 |
Why?
|
Consensus | 1 | 2021 | 3212 | 0.020 |
Why?
|
Platelet Activation | 1 | 2015 | 644 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2022 | 3711 | 0.020 |
Why?
|
Information Storage and Retrieval | 1 | 2007 | 830 | 0.020 |
Why?
|
Antibodies, Neutralizing | 1 | 2021 | 2011 | 0.020 |
Why?
|
Electrocardiography, Ambulatory | 1 | 2003 | 582 | 0.020 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2011 | 267 | 0.020 |
Why?
|
Age Factors | 2 | 2020 | 18412 | 0.020 |
Why?
|
Electrophysiologic Techniques, Cardiac | 1 | 2003 | 511 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2023 | 14729 | 0.020 |
Why?
|
Middle Aged | 4 | 2021 | 223492 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2021 | 11095 | 0.020 |
Why?
|
Data Collection | 1 | 2007 | 3327 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9374 | 0.020 |
Why?
|
Hospitalization | 2 | 2020 | 10840 | 0.020 |
Why?
|
Costs and Cost Analysis | 1 | 2003 | 1667 | 0.020 |
Why?
|
Quality Improvement | 1 | 2022 | 3857 | 0.020 |
Why?
|
Heparin | 1 | 2014 | 1636 | 0.020 |
Why?
|
Osmolar Concentration | 1 | 2007 | 657 | 0.020 |
Why?
|
Dehydration | 1 | 2007 | 216 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10590 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2023 | 20227 | 0.020 |
Why?
|
Blood Platelets | 1 | 2015 | 2479 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2015 | 3139 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2007 | 12252 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2007 | 1836 | 0.010 |
Why?
|
Reoperation | 1 | 2003 | 4329 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2014 | 8542 | 0.010 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2014 | 2763 | 0.010 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2003 | 2145 | 0.010 |
Why?
|
Recurrence | 1 | 2003 | 8509 | 0.010 |
Why?
|
Echocardiography | 1 | 2003 | 5047 | 0.010 |
Why?
|
Hyperglycemia | 1 | 2007 | 1388 | 0.010 |
Why?
|
Stroke Volume | 1 | 2003 | 5622 | 0.010 |
Why?
|
Anticoagulants | 1 | 2014 | 4852 | 0.010 |
Why?
|
Odds Ratio | 1 | 2009 | 9669 | 0.010 |
Why?
|
Phenotype | 1 | 2015 | 16726 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2012 | 15454 | 0.010 |
Why?
|
Aged | 2 | 2021 | 171504 | 0.010 |
Why?
|
Logistic Models | 1 | 2008 | 13290 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2003 | 39348 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2003 | 15832 | 0.010 |
Why?
|
Inflammation | 1 | 2008 | 10873 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2014 | 36743 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2003 | 65371 | 0.000 |
Why?
|